These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 57244)
1. Comparative trial of thiacetazone with isoniazid and paraaminosalicyclic acid (PAS) with isoniazid in the treatment of pulmonary tuberculosis in Nigerians. Onadeko BO; Sofowora EO J Trop Med Hyg; 1975 Sep; 78(9):201-5. PubMed ID: 57244 [TBL] [Abstract][Full Text] [Related]
2. Comparative studies with isoniazid alone, isoniazid with thiacetazone and isoniazid with para-aminosalicylic acid in ambulatory treatment of pulmonary tuberculosis. Patel RB; Patel TL; Mehta HC J Indian Med Assoc; 1967 May; 48(10):471-8. PubMed ID: 4167188 [No Abstract] [Full Text] [Related]
3. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report. Ige OM; Bakare NA; Onadeko BO Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469 [TBL] [Abstract][Full Text] [Related]
4. Intermittent chemotherapy with thiacetazone and isoniazid in the treatment of pulmonary tuberculosis. Krishnaswami KV Indian J Chest Dis Allied Sci; 1977 Oct; 19(4):177-87. PubMed ID: 77844 [No Abstract] [Full Text] [Related]
5. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda. Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; RĂ¼sch-Gerdes S East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516 [TBL] [Abstract][Full Text] [Related]
6. Streptomycin plus thiacetazone (thioacetazone) compared with streptomycin plus PAS and with isoniazid plus thiacetazone in the treatment of pulmonary tuberculosis in Rhodesia. Briggs IL; Rochester WR; Shennan DH; Riddell RW; Fox W; Heffernan JF; Miller AB; Nunn AJ; Stott H; Tall R Tubercle; 1968 Mar; 49(1):48-69. PubMed ID: 4173466 [No Abstract] [Full Text] [Related]
7. A controlled comparison of thiacetazone (thioacetazone) plus isoniazid with PAS plus isoniazid in Hong Kong. Tubercle; 1968 Sep; 49(3):243-80. PubMed ID: 4179210 [No Abstract] [Full Text] [Related]
8. Thiacetazone toxicity in the treatment of tuberculosis patients in Nigeria. Pearson CA J Trop Med Hyg; 1978 Dec; 81(12):238-42. PubMed ID: 85717 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients. Prasad R; Verma SK; Sahai S; Kumar S; Jain A Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675 [TBL] [Abstract][Full Text] [Related]
10. A thiacetazone toxicity trial in Sarawak. Webb AH N Z Med J; 1973 Nov; 78(502):490-12. PubMed ID: 4129254 [No Abstract] [Full Text] [Related]
11. Value of isoniazid-thiacetazone combination in unsupervised ambulatory cases of pulmonary tuberculosis. Narang RK Indian Pract; 1967 Jul; 20(7):465-8. PubMed ID: 4169024 [No Abstract] [Full Text] [Related]
12. Comparative trial of ethambutol and thiacetazone in childhood tuberculosis. Goel J; Singh H; Dhatt PS; Gupta HL Indian Pediatr; 1979 Jun; 16(6):527-31. PubMed ID: 93089 [No Abstract] [Full Text] [Related]
13. [Controlled study of the combination isoniazid-thioacetazone in the treatment of lung tuberculosis]. do Prado WT; Gomes Sde C AMB Rev Assoc Med Bras; 1974 Nov; 20(11):399-402. PubMed ID: 4141511 [No Abstract] [Full Text] [Related]
14. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]
15. Concurrent comparison of an unsupervised daily oral regimen of thiacetazone plus isoniazid and a fully supervised twice-weekly regimen of streptomycin plus isoniazid in the domiciliary treatment of pulmonary tuberculosis--a co-operative investigation. Menon K Bull Int Union Tuberc; 1974 Aug; 49 suppl 1():131-2. PubMed ID: 4143180 [No Abstract] [Full Text] [Related]
16. Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania. Dukes CS; Sugarman J; Cegielski JP; Lallinger GJ; Mwakyusa DH Trop Geogr Med; 1992 Oct; 44(4):308-11. PubMed ID: 1284179 [TBL] [Abstract][Full Text] [Related]
17. A comparative study of daily and twice-weekly continuation regimens of tuberculosis chemotherapy, including a comparison of two durations of sanatorium treatment. 2. Second report: the results from 12 to 24 months. Who Collaborating Centre For Tuberculosis Chemotherapy Bull World Health Organ; 1973; 48(2):155-65. PubMed ID: 4578361 [TBL] [Abstract][Full Text] [Related]
18. Rifampicin plus isoniazid, rifampicin plus PAS, and isoniazid plus PAS in the initial treatment of pulmonary tuberculosis. A controlled multicenter clinical trial. Tousek J; Votruba R Chemotherapy; 1974; 20(3):183-200. PubMed ID: 4605071 [No Abstract] [Full Text] [Related]
19. [In 76% of patients with active tuberculosis treated with triple therapy (isoniazid-rifampicin-pyrazinamide) cultural conversion precedes microscopic conversion]. Nowak D; Radenbach D; Magnussen H Pneumologie; 1990 Feb; 44 Suppl 1():497-8. PubMed ID: 2114634 [TBL] [Abstract][Full Text] [Related]
20. [The therapeutic efficacy of a streptomycin-hydrazide-thiacetazone regimen with different dosages of thiacetazone in pulmonary tuberculosis]. Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Apr; 9(2):72-6, 125. PubMed ID: 2427291 [No Abstract] [Full Text] [Related] [Next] [New Search]